Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report
Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency ane...
Main Authors: | Minhee Lee, Tae Hee Kim, Se Jeong Kim, Byung Chul Jee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology
2019-01-01
|
Series: | Obstetrics & Gynecology Science |
Subjects: | |
Online Access: | http://ogscience.org/upload/pdf/ogs-62-69.pdf |
Similar Items
-
Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01) -
Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01) -
Vaginal Expulsion of a Submucosal Myoma During Treatment with Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Lily Wen, et al.
Published: (2006-06-01) -
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial
by: L. L. Engmann, et al.
Published: (2019-01-01) -
Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)